Catheter-based renal sympathectomy

Journal of Cardiovascular Surgery

Volumn 51, Issue 5, 2010, Pages 721-739

  Id, D ^a   Bertog, S C ^a   Wunderlich, N ^a   Sievert, H ^a  

^a CARDIOVASCULAR CENTER FRANKFURT   (Germany)

Author keywords

Denervation; Hypertension; Sympathectomy

Indexed keywords

ADRENERGIC SYSTEM; BLOOD PRESSURE REGULATION; HUMAN; HYPERTENSION; KIDNEY; KIDNEY DENERVATION; KIDNEY NERVE; KIDNEY TRANSPLANTATION; NEPHRECTOMY; NERVE CONDUCTION; NEUROGRAPHY; NONHUMAN; REVIEW; SENSORY NERVE CONDUCTION; SYMPATHECTOMY; SYMPATHETIC TRUNK;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CATHETERIZATION; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; KIDNEY; NEPHRECTOMY; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TREATMENT OUTCOME;

EID: 78650729724     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (124)

1. Franco OH, Peeters A, Bonneux L, de Laet C. Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis. Hypertension 2005; 46: 280-6. (Pubitemid 41099158)
2. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13. (Pubitemid 35472129)
3. Verdecchia P Gentile G, Angeli F, Mazzotta G, Maneia G, Reboldi G. Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials. J Hypertens 2010; 28: 1356-65.
4. Cohen JD. Hypertension epidemiology and economic burden: refining risk assessment to lower costs. Manag Care 2009; 18: 51-8.
5. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 480-6.
6. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51: 1403-19.
7. Pisoni R, Ahmed MI, Calhoun Da. Characterization and treatment of resistant hypertension. Curr Cardiol Rep 2009; 11: 407-13.
8. Otero FR, Grigorian LS, Lado ML, Lado AL, Turrado VT, Santos JA et al. [Association between refractory hypertension and cardiometabolic risk. The HIPERFRE study). Nefrologia 2008; 28: 425-32.
9. Armario P, Oliveras A, Hernández Del Rey R, Poch E, Larrouse M, Roca-Cusachs A et al. [Prevalence of target organ damage and factors associated with cardiovascular events in subjects with refractory hypertension]. Med Clin (Bare), 2009; 133: 127-31.
10. Lubanski MS, McCullough PA. Kidney's role in hypertension. Minerva Cardioangiol 2009; 57: 743-59.
11. Castrop H, Höcherl K, Kurtz A, Schweda F, Todorov V, Wagner C. Physiology of kidney renin. Physiol Rev 2010; 90: 607-73.
12. Cowley AW, Jr., Liard JF, Guyton AC. Role of baroreceptor reflex in daily control of arterial blood pressure and other variables in dogs. Circ Res 1973; 32: 564-76.
13. Rettig R. Does the kidney play a role in the aetiology of primary hypertension' Evidence from renal transplantation studies in rats and humans. J Hum Hypertens 1993; 7: 177-80. (Pubitemid 23138195)
14. Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl 1996; 14. S159-65.
15. Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 2010; 90: 513-57.
16. Mancia G. The sympathetic nervous system and the metabolic syndrome. J Hypertens 2007; 25: 909-20. (Pubitemid 46573105)
17. Barajas L, Liu L, Powers K. Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Can J Physiol Pharmacol 1992; 70: 735-49.
18. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77: 75-197.
19. Osborn JW, Hornfeldt BJ. Arterial baroreceptor denervation impairs long-term regulation of arterial pressure during dietary salt loading. Am J Physiol 1998; 275; H1558-66.
20. Matthews KA, Katholi CR, McCreath H, Whooley MA, Williams DR, Zhu S et al. Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation 2004; 110: 74-8. (Pubitemid 38880136)
21. Goldstein DS, Lake CR, Chernow B, Ziegler MG, Coleman MD, Taylor AA et al. Age-dependence of hypertensive-normotensive differences in plasma norepinephrine. Hypertension 1983; 5: 100-4. (Pubitemid 13179795)
22. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989; 14: 177-83.
23. Floras JS, Hara K. Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension. J Hypertens 1993; 11: 647-55. (Pubitemid 23225208)
24. Rogenes PR, Gottschalk CW. Renal function in conscious rats with chronic unilateral renal denervation. Am J Physiol 1982; 242: F140-8.
25. Wilcox CS, Aminoff MJ, Slater JD. Sodium homeostasis in patients with autonomic failure. Clin Sei Mol Med 1977; 53: 321-8.
26. DiBona GF, Jones SY, Sawin LL. Renal sympathetic neural mechanisms as intermediate phenotype in spontaneously hypertensive rats. Hypertension 1996; 27(3 Pt 2): 626-30.
27. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2010; 298: R245-53.
28. Moss NG. Renal function and renal afferent and efferent nerve activity. Am J Physiol 1982; 243: F425-33.
29. Slick GL, Aguilera AJ, Zambraski EJ, DiBona GF, Kaloyanides GJ. Renal neuroadrenergic transmission. AmJ Physiol 1975; 229: 60-5.
30. DiBona GF, Sawin LL, Jones SY. Characteristics of renal sympathetic nerve activity in sodium-retaining disorders. Am J Physiol 1996; 271(1 Pt 2): R295-302.
31. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br J Pharmacol 2010; 159: 438-48.
32. DiBona GF. Nervous kidney. Interaction between renal sympathetic nerves and the renin-angiotensin system in the control of renal function. Hypertension 2000; 36: 1083-8.
33. DiBona GF. Neural control of renal tubular sodium reabsorption of the dog. Fed Proc 1978; 37: 1214-7.
34. Wu X, Scholey JW, Sonnenberg H, Melo LG. Renal vascular morphology and haemodynamics in Dahl salt-sensitive rats on high salt-low potassium diet: neural and genetic influences. J Hypertens 2000; 18: 783-93. (Pubitemid 30406752)
35. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 1999; 79: 143-80. (Pubitemid 29056951)
36. Kopp UC, Jones SY, DiBona GF. Afferent renal denervation impairs baroreflex control of efferent renal sympathetic nerve activity. Am J Physiol Regul Integr Comp Physiol 2008; 295 :R1882-90.
37. Ciriello J, de Oliveira CV. Renal afferents and hypertension. Curr Hypertens Rep 2002; 4: 136-42.
38. Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 2002; 15: 717-24. (Pubitemid 34804278)
39. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure. Kidney Int 1997; 51: 722-7. (Pubitemid 27157956)
40. Schlaich MP, Sobotka PA, Krum H, Whitbourn R, Walton A, Esler MD. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept. Hypertension 2009; 54: 1195-201.
41. Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res 2010; 33: 521-842.
42. Vallbo AB, Hagbarth KE, Wallin BG. Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J Appl Physiol 2004; 96: 1262-9.
43. Vallbo AB, Hagbarth KE, Torebjörk HE, Wallin BG. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol Rev 1979; 59: 919-57.
44. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 1984; 247(1 Pt 1): E21-8.
45. Esler M, Jennings G, Korner P, Blombery P, Burke F, Willett I et al. Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension. Clin Exp Hypertens A 1984, 6: 507-21.
46. Wallin BG, Thompson JM, Jennings GL, Esler MD. Renal noradrenaline spillover correlates with muscle sympathetic activity in humans. J Physiol 1996; 49(Pt 3): 881-7.
47. Esler M, Jennings G, Biviano B, Lambert G, Hasking G. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 1986; 8(Suppl 5): S39-43.
48. Schlaich MP, Lambert E, Kaye DM, Krozowski Z, Campbell DJ, Lambert G et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation. Hypertension 2004; 43: 169-75.
49. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. AmJ Hypertens 1989; 2(3 Pt 2): 140S-146S.
50. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73: 615-21.
51. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J 2005; 26: 906-13.
52. Goldblatt H, Lynch J, Hanzal RF, Summerville WW. Studies on experimental hypertension : i. the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med 1934; 59: 347-379.
53. Allbutt TC. Arterial diseases. Br Med J 1906; 1: 169-170.
54. Wilks S. Cases of Bright's disease, with remarks. Guy's Hosp Rep 1853; 15: 232-315.
55. Prinzmetal M, Wilson C. The nature of the peripheral resistance in arterial hypertension with special reference to the vasomotor system. J Clin Invest 1936; 15: 63-83.
56. Smithwick RH. The role of the sympathetic nervous system in essential hypertension in man. Angiology 1951; 2: 227-42.
57. Grimson KS. Total thoracic and partial to total lumbar sympathectomy and celiac ganglionectomy in the treatment of hypertension. Ann Surg 1941; 114: 753-75.
58. Boyd JD, Monro PA. Partial retention of autonomic function after paravertebral sympathectomy, intermediate lumbar sympathetic ganglia as the probable explanation. Lancet 1949; 2: 892-5.
59. Peet, M.M. and E.M. Isberg, The surgical treatment of arterial hypertension. Med Press Egypt, 1946. 38(6): p. 176-85.
60. Levitt WM, Oram S. Irradiation-induced malignant hypertension: cured by nephrectomy. Br Med J 1956; 2: 910-2.
61. Maitland AI. The effect of splanchnicectomy on renal function. Lancet 1950; 2: 7-10.
62. Thorpe JJ, Welch WJ, Poindexter CA. Bilateral thoracolumbar sympathectomy for hypertension; a study of 500 cases. Am J Med 1950; 9: 500-15.
63. Peet MM, Woods WW, Braden S. The surgical treatmentof hypertension:results in 350 consecutive cases treated bybilateral supradiaphragmatic splanchicectomy and lower dorsal sympathetic ganglionectomy clinical lecture at New York Session. J Am Med Assoc 1940; 115: 1875-85.
64. Smithwick RH. Surgery in hypertension. Lancet 1948; 2: 65.
65. Grimson KS, Orgain ES, Anderson B, Broome RA, Longino FH. Results of treatment of patients with hypertension by total thoracic and partial to total lumbar sympathectomy, splanchnicectomy and celiac ganglionectomy. Ann Surg 1949; 129: 850-71.
66. Evelyn KA, Alexander F, Cooper SR. Effect of sympathectomy on blood pressure in hypertension; a review of 13 years' experience of the Massachusetts General Hospital. J Am Med Assoc 1949; 140: 592-602.
67. Hinton JW. End results of thoracolumbar sympathectomy for advanced essential hypertension. Bull N Y Acad Med 1948; 24: 239-52.
68. Hammarstrom S, Bechgaard P. Prognosis in arterial hypertension; comparison between 251 patients after sympathectomy and selected series of 435 non-operated patients. Am J Med 1950; 8: 53-6.
69. Doyle AE. Treatment of hypertension. Br Heart J 1971; 33: Suppl: 113-5.
70. Hinton JW. End results of thoracolumbar sympathectomy for advanced essential hypertension. Calif Med 1949; 70: 282-7.
71. Longland CJ, Gibb WE. Sympathectomy in the treatment of benign and malignant hypertension; a review of 76 patients. Br J Surg 1954; 41: 382-92.
72. Schuster G, 3rd, Schoen AM, Grisworld RA. The incidence of peptic ulcer following sympathectomy for hypertension. A presentation of a case. South Surg 1950; 16: 172-80.
73. De Takats G. Sympathectomy for hypertension. Am J Surg 1974; 127: 521-4.
74. Dodson AI. Indications for nephrectomy in non-malignant diseases of the kidney. 1924: 277-81.
75. Ask-Upmark E. Über juvenile maligne Nephrosclerose und ihr Verhältnis zu Störungen in der Nierenentwicklung. Acta Path Microbiol Scand 1929; 6: 383-442.
76. Butler AM. Chronic pyelonephritis and arterial hypertension. J Clin Invest 1937; 16: 889-97.
77. Smith HW. Hypertension and urologie disease. Am J Med 1948; 4: 724-43.
78. Fitz A. Renal venous renin determinations in the diagnosis of surgically correctable hypertension. Circulation 1967; 36: 942-50.
79. Perry CB. Malignant hypertension cured by unilateral nephrectomy. Br Heart J 1945; 7: 139-42.
80. Braasch WF. The surgical kidney as an etiological factor in hypertension. Can Med Assoc J 1942; 46.9-15.
81. Goldring W. The management of hypertension. Bull N Y Acad Med 1943; 19: 317-39.
82. Kincaid-Smith P. Vascular obstruction in chronic pyelonephritic kidneys and its relation to hypertension. Lancet 1955; 269: 1263-9.
83. Adams LJ. Hypertension and unilateral kidney disease; late results of nephrectomy in seven patients. Can Med Assoc J 1955; 73: 800-4.
84. Smith HW. Unilateral nephrectomy in hypertensive disease. J Urol 1956; 76: 685-701.
85. Salem M. Hypertension in the haemodialysis population: any relationship to 2-years survival? Nephrol Dial Transplant 1999; 14: 125-8.
86. Merrill JP, Schupak E. Mechanisms of hypertension in renoprival man. Can Med Assoc J 1964; 90: 328-32.
87. West TH, Turcotte JG, Vander A. Plasma renin activity, sodium balance, and hypertension in a group of renal transplant recipients. J Lab Clin Med 1969; 73: 564-73.
88. Wilkinson R, Scott DF, Uldall PR, Kerr DN, Swinney J. Plasma renin and exchangeable sodium in the hypertension of chronic renal failure. The effect of bilateral nephrectomy. Q J Med 1970; 39: 377-94.
89. El-Said WM. Bilateral nephrectomy as a treatment of malignant hypertension. Int Urol Nephrol 1974; 6: 209-16.
90. Medina A, Bell PR, Briggs JD, Brown JJ, Fine A, Lever AF et al. Changes of blood pressure, renin, and angiotensin after bilateral nephrectomy in patients with chronic renal failure. Br Med J 1972; 4: 694-6.
91. Lee DB, Ehrlich RM, Dabir-Vaziri N, Sambhi MP, Doud RB, Barajas L et al. Post-transplant hypertension. Normoreninemic severe hypertension treated by bilateral nephrectomies. Urology 1977; 9: 425-8.
92. Augustyniak RA, Picken MM, Leonard D, Zhou XJ, Zhang W, Victor RG. Sympathetic nerves and the progression of chronic kidney disease during 5/6 nephrectomy: studies in sympathectomized rats. Clin Exp Pharmacol Physiol 2010; 37: 12-8.
93. Cohen SL. Hypertension in renal transplant recipients: role of bilateral nephrectomy. Br Med J 1973; 3: 78-81.
94. McHugh MI, Tanboga H, Marcen R, Liano F, Robson V, Wilkinson R. Hypertension following renal transplantation: the role of the host's kidney. Q J Med 1980; 49: 395-403. (Pubitemid 11210091)
95. Curtis JJ, Lucas BA, Kotchen TA, Luke RG. Surgical therapy for persistent hypertension after renal transplantation. Transplantation 1981; 31: 125-8.
96. Getts RT, Hazlett SM, Sharma SB, McGill RL, Biederman RW, Marcus RJ et al. Regression of left ventricular hypertrophy after bilateral nephrectomy. Nephrol Dial Transplant 2006; 21: 1089-91.
97. Fricke L, Doehn C, Steinhoff J, Sack K, Jocham D, Fornara P. Treatment of posttransplant hypertension by laparoscopic bilateral nephrectomy? Transplantation 1998; 65: 1182-7.
98. Huysmans FT, Koene RAP. Antihypertensive effect of beta blockade in renal transplant recipients with or without host kidneys. Transplantation 1988; 46: 234-7.
99. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F et al. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-8.
100. Hausberg M, Tokmak F, Pavenstädt H, Krämer BK, Rump LC. Sympathetic nerve activity in end-stage renal disease. Circulation;2002; 106: 1974-9.
101. Ritz E, Amann K, Fliser D. The sympathetic nervous system and the kidney: its importance in renal diseases. Blood Press 1998; Suppl 3: 14-9. (Pubitemid 29185400)
102. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F et al. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340: 1321-8.
103. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol 2003; 14: 425-30. (Pubitemid 36150866)
104. Neumann J, Ligtenberg G, Oey L, Koomans HA, Blankestijn PJ. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure. J Am Soc Nephrol 2004; 15: 2902-7. (Pubitemid 41103399)
105. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O et al. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 1991; 17(6 Pt 2): 1057-62.
106. Campese VM. A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications. Clin Exp Nephrol 2003; 7: 167-71.
107. Ye S, Zhong H, Yanamadala S, Campese VM. Oxidative stress mediates the stimulation of sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 2006; 48: 309-15.
108. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Jensen G et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99: 2537-42.
109. Liard JF. Renal denervation delays blood pressure increase in the spontaneously hypertensive rat. Experientia 1977; 33: 339-40.
110. Hendel MD, Collister JP. Renal denervation attenuates long-term hypertensive effects of Angiotensin ii in the rat. Clin Exp Pharmacol Physiol 2006; 33: 1225-30.
111. Jacob F, Clark LA, Guzman PA, Osborn JW. Role of renal nerves in development of hypertension in DOCA-salt model in rats: a telemetric approach. Am J Physiol Heart Circ Physiol 2005; 289: H1519-29.
112. Kline RL, Kelton PM, Mercer PF. Effect of renal denervation on the development of hypertension in spontaneously hypertensive rats. Can J Physiol Pharmacol 1978; 56: 818-22.
113. Abramczyk P, Zwoliñska A, Oficjalski P, Przybylski J. Kidney denervation combined with elimination of adrenal-renal portal circulation prevents the development of hypertension in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1999; 26: 32-4.
114. Shweta A, Denton KM, Kett MM, Bertram JF, Lambert GW, Anderson WP. Paradoxical structural effects in the unilaterally denervated spontaneously hypertensive rat kidney. J Hypertens 2005; 23: 851-9.
115. Recordati G, Zorzoli F, Zanchetti A. Effects of a reversible 'nephrectomy' on renal sympathetic activity and blood pressure in the rat: evidence for an acute angiotensin-mediated hypertension. J Hypertens 2000; 18: 1277-87.
116. Katholi RE. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol 1983; 245: F1-14.
117. Dzielak DJ, Norman RA, Jr. Renal nerves are not necessary for onset or maintenance of DOC-salt hypertension in rats. Am J Physiol 1985; 249(5 Pt 2): H945-9.
118. Nakada T, Kubota Y, Suzuki H, Sasagawa I, Watanabe M, Ishigooka M. Suppression of sympathetic nervous system attenuates the development of two-kidney, one-clip Goldblatt hypertension. J Urol 1996; 156: 1480-4.
119. Kalaitzis C, Touloupidis S, Bantis E, Patris E, Triantafyllidis A. Effects of renal denervation of the contralateral kidney on blood pressure and sodium and eicosanoid excretion in the chronic phase of two-kidney, one-clip renovascular hypertension in rats. Scand J Urol Nephrol 2005; 39: 15-20.
120. Moretti JL, Burke SL, Evans RG, Lambert GW, Head GA. Enhanced responses to ganglion blockade do not reflect sympathetic nervous system contribution to angiotensin II-induced hypertension. J Hypertens 2009; 27: 1838-48.
121. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25(4 Pt 2): 893-7.
122. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373: 1275-81.
123. Skarphedinsson JO, Elam M, Jungersten L, Wallin BG. Sympathetic nerve traffic correlates with the release of nitric oxide in humans: implications for blood pressure control. J Physiol 1997; 501(Pt 3): 671-5.
124. Grassi G, Cattaneo BM, Seravalle G, Lanfranchi A, Maneia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension. Hypertension 1998; 31: 68-72.